Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) FCF Margin (2016 - 2025)

Abeona Therapeutics has reported FCF Margin over the past 13 years, most recently at 472.82% for Q4 2025.

  • Quarterly results put FCF Margin at 472.82% for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 1448.47% (changed N/A YoY), and the annual figure for FY2025 was 1448.47%, changed.
  • FCF Margin for Q4 2025 was 472.82% at Abeona Therapeutics, up from 4686.75% in the prior quarter.
  • Over the last five years, FCF Margin for ABEO hit a ceiling of 69802.08% in Q4 2021 and a floor of 20613.24% in Q4 2022.
  • Median FCF Margin over the past 4 years was 383.78% (2023), compared with a mean of 4219.35%.
  • Biggest five-year swings in FCF Margin: surged 6985685bps in 2021 and later crashed -9041532bps in 2022.
  • Abeona Therapeutics' FCF Margin stood at 69802.08% in 2021, then plummeted by -130bps to 20613.24% in 2022, then soared by 99bps to 294.74% in 2023, then tumbled by -60bps to 472.82% in 2025.
  • The last three reported values for FCF Margin were 472.82% (Q4 2025), 4686.75% (Q2 2025), and 294.74% (Q2 2023) per Business Quant data.